Skip to main content

Drug Interactions between palopegteriparatide and tiludronate

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

tiludronate palopegteriparatide

Applies to: tiludronate and palopegteriparatide

Tiludronate may alter the effects of palopegteriparatide in regulating the amount of calcium in your blood. You may need extra monitoring to safely use both drugs. Talk to your doctor if you have any questions or concerns. Contact your doctor promptly if your condition changes or you develop symptoms of high levels of calcium in the blood (hypercalcemia) such as nausea, vomiting, constipation, lethargy, muscle weakness. Likewise, contact your doctor as soon as possible if you develop symptoms of low levels of calcium in the blood (hypocalcemia) such as numbness or tingling around your mouth, muscle cramps, uncontrolled muscle movements, irritability, depression, irregular heartbeats, or confusion. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Drug and food interactions

Moderate

tiludronate food

Applies to: tiludronate

Food significantly decreases the levels of tiludronate. Tiludronate should be administered on an empty stomach with 6 to 8 ounces of plain water at least 2 hours before or 2 hours after food. This will make it easier for your body to absorb the medication.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer